Selected research
Industry Research
lncRNA Sequencing Service Industry Research Report 2026
Market perspective
The global lncRNA Sequencing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the lncRNA Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the lncRNA Sequencing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the lncRNA Sequencing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of lncRNA Sequencing Service include LC Sciences, Creative Biolabs, Eurofins Scientific, CD Genomics, Novogene Co, Ltd., Beijing Compass Biotechnology Co., Ltd., Biomarker Technologies, Azenta and BGI Genomics and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global lncRNA Sequencing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to lncRNA Sequencing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
lncRNA Sequencing Service Market by Company
LC Sciences
Creative Biolabs
Eurofins Scientific
CD Genomics
Novogene Co, Ltd.
Beijing Compass Biotechnology Co., Ltd.
Biomarker Technologies
Azenta
BGI Genomics
Annoroad Gene Technology
lncRNA Sequencing Service Segment by Type
Normal-depth Sequencing
High-depth Sequencing
lncRNA Sequencing Service Segment by Application
Agriculture
Medical
lncRNA Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global lncRNA Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of lncRNA Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of lncRNA Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of lncRNA Sequencing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Normal-depth Sequencing
- High-depth Sequencing
Applications
- Agriculture
- Medical
Companies covered
- LC Sciences
- Creative Biolabs
- Eurofins Scientific
- CD Genomics
- Novogene Co, Ltd.
- Beijing Compass Biotechnology Co., Ltd.
- Biomarker Technologies
- Azenta
- BGI Genomics
- Annoroad Gene Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 lncRNA Sequencing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Normal-depth Sequencing
- 2.2.3 High-depth Sequencing
- 2.3 lncRNA Sequencing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Agriculture
- 2.3.3 Medical
- 2.4 Assumptions and Limitations
3 lncRNA Sequencing Service Breakdown Data by Type
- 3.1 Global lncRNA Sequencing Service Historic Market Size by Type (2021-2026)
- 3.2 Global lncRNA Sequencing Service Forecasted Market Size by Type (2027-2032)
4 lncRNA Sequencing Service Breakdown Data by Application
- 4.1 Global lncRNA Sequencing Service Historic Market Size by Application (2021-2026)
- 4.2 Global lncRNA Sequencing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global lncRNA Sequencing Service Market Perspective (2021-2032)
- 5.2 Global lncRNA Sequencing Service Growth Trends by Region
- 5.2.1 Global lncRNA Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 lncRNA Sequencing Service Historic Market Size by Region (2021-2026)
- 5.2.3 lncRNA Sequencing Service Forecasted Market Size by Region (2027-2032)
- 5.3 lncRNA Sequencing Service Market Dynamics
- 5.3.1 lncRNA Sequencing Service Industry Trends
- 5.3.2 lncRNA Sequencing Service Market Drivers
- 5.3.3 lncRNA Sequencing Service Market Challenges
- 5.3.4 lncRNA Sequencing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top lncRNA Sequencing Service Players by Revenue
- 6.1.1 Global Top lncRNA Sequencing Service Players by Revenue (2021-2026)
- 6.1.2 Global lncRNA Sequencing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global lncRNA Sequencing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of lncRNA Sequencing Service Head Office and Area Served
- 6.4 Global lncRNA Sequencing Service Players, Product Type & Application
- 6.5 Global lncRNA Sequencing Service Manufacturers Established Date
- 6.6 Global lncRNA Sequencing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America lncRNA Sequencing Service Market Size (2021-2032)
- 7.2 North America lncRNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America lncRNA Sequencing Service Market Size by Country (2021-2026)
- 7.4 North America lncRNA Sequencing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe lncRNA Sequencing Service Market Size (2021-2032)
- 8.2 Europe lncRNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe lncRNA Sequencing Service Market Size by Country (2021-2026)
- 8.4 Europe lncRNA Sequencing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific lncRNA Sequencing Service Market Size (2021-2032)
- 9.2 Asia-Pacific lncRNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific lncRNA Sequencing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific lncRNA Sequencing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America lncRNA Sequencing Service Market Size (2021-2032)
- 10.2 South America lncRNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America lncRNA Sequencing Service Market Size by Country (2021-2026)
- 10.4 South America lncRNA Sequencing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa lncRNA Sequencing Service Market Size (2021-2032)
- 11.2 Middle East & Africa lncRNA Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa lncRNA Sequencing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa lncRNA Sequencing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 LC Sciences
- 12.1.1 LC Sciences Company Information
- 12.1.2 LC Sciences Business Overview
- 12.1.3 LC Sciences Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.1.4 LC Sciences lncRNA Sequencing Service Product Portfolio
- 12.1.5 LC Sciences Recent Developments
- 12.2 Creative Biolabs
- 12.2.1 Creative Biolabs Company Information
- 12.2.2 Creative Biolabs Business Overview
- 12.2.3 Creative Biolabs Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.2.4 Creative Biolabs lncRNA Sequencing Service Product Portfolio
- 12.2.5 Creative Biolabs Recent Developments
- 12.3 Eurofins Scientific
- 12.3.1 Eurofins Scientific Company Information
- 12.3.2 Eurofins Scientific Business Overview
- 12.3.3 Eurofins Scientific Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.3.4 Eurofins Scientific lncRNA Sequencing Service Product Portfolio
- 12.3.5 Eurofins Scientific Recent Developments
- 12.4 CD Genomics
- 12.4.1 CD Genomics Company Information
- 12.4.2 CD Genomics Business Overview
- 12.4.3 CD Genomics Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.4.4 CD Genomics lncRNA Sequencing Service Product Portfolio
- 12.4.5 CD Genomics Recent Developments
- 12.5 Novogene Co, Ltd.
- 12.5.1 Novogene Co, Ltd. Company Information
- 12.5.2 Novogene Co, Ltd. Business Overview
- 12.5.3 Novogene Co, Ltd. Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.5.4 Novogene Co, Ltd. lncRNA Sequencing Service Product Portfolio
- 12.5.5 Novogene Co, Ltd. Recent Developments
- 12.6 Beijing Compass Biotechnology Co., Ltd.
- 12.6.1 Beijing Compass Biotechnology Co., Ltd. Company Information
- 12.6.2 Beijing Compass Biotechnology Co., Ltd. Business Overview
- 12.6.3 Beijing Compass Biotechnology Co., Ltd. Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.6.4 Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Product Portfolio
- 12.6.5 Beijing Compass Biotechnology Co., Ltd. Recent Developments
- 12.7 Biomarker Technologies
- 12.7.1 Biomarker Technologies Company Information
- 12.7.2 Biomarker Technologies Business Overview
- 12.7.3 Biomarker Technologies Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.7.4 Biomarker Technologies lncRNA Sequencing Service Product Portfolio
- 12.7.5 Biomarker Technologies Recent Developments
- 12.8 Azenta
- 12.8.1 Azenta Company Information
- 12.8.2 Azenta Business Overview
- 12.8.3 Azenta Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.8.4 Azenta lncRNA Sequencing Service Product Portfolio
- 12.8.5 Azenta Recent Developments
- 12.9 BGI Genomics
- 12.9.1 BGI Genomics Company Information
- 12.9.2 BGI Genomics Business Overview
- 12.9.3 BGI Genomics Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.9.4 BGI Genomics lncRNA Sequencing Service Product Portfolio
- 12.9.5 BGI Genomics Recent Developments
- 12.10 Annoroad Gene Technology
- 12.10.1 Annoroad Gene Technology Company Information
- 12.10.2 Annoroad Gene Technology Business Overview
- 12.10.3 Annoroad Gene Technology Revenue in lncRNA Sequencing Service Business (2021-2026)
- 12.10.4 Annoroad Gene Technology lncRNA Sequencing Service Product Portfolio
- 12.10.5 Annoroad Gene Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst